The present research work is a descriptive and cross-sectional study, in which 1500 gastric biopsies collected from 500 dyspeptic patients were processed with the aim of isolating and cultivating H. pylori strains, determining the resistance profiles in vitro and identify genetic mutations in the rRNA23S, pbp1, gyrA, rdxA and rRNA16S genes to determine the statistical significance and prevalence ratios between antimicrobial resistance to Clarithromycin, Amoxicillin, Levofloxacin, Metronidazole and Tetracycline respectively. As results, a prevalence of 54.6% of dyspeptic patients with H. pylori was obtained with antimicrobial resistance of: Clarithromycin 35.2%, Amoxicillin 65.3%, Metronidazole 68.9%, Levofloxacin 72.1% and Tetracycline 7.8%. In addition, mutations A2143G, A2142G and A2142C are identified within the rRNA23S and N87I, D91G, N87K, D91N and D91Y genes within the gyrA gene, s...